Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

Effective September 8, 2021, Warren Schlichting resigned from his position as Chief Executive Officer of Progress Acquisition Corp. (the "Company"). Mr.Schlichting will remain as a director of the Company.

Effective September 8, 2021, David Arslanian, the Company's President, was appointed as Chief Executive Officer of the Company. There is no arrangement or understanding between Mr. Arslanian and any other person pursuant to which he was named Chief Executive Officer of the Company.

Mr. Arslanian has served as the Company's President since inception. Mr. Arslanian joined Progress Partners Inc., an investment bank and corporate advisory firm, in January 2018 as managing director. He has extensive experience in tech, finance, and strategic partnerships. Prior to this, Mr. Arslanian held many C-level operating roles with various emerging tech companies in financial services and marketing. Most recently, he was vice president of corporate development and strategic partnerships at Telaria, Inc. (NYSE: TLRA), a software platform that optimizes yield for leading video publishers, which merged with The Rubicon Project, Inc. in April 2020 and the entity was renamed Magnite (NYSE: MGNI). Mr. Arslanian is board member at Inanovate, Inc., a life sciences company that uses proprietary blood screening technology to develop reliable low-cost blood tests for improved cancer diagnosis. Mr. Arslanian was, from August 2010 to February 2011, Chief Operating Officer of Rovion, Inc. He is also a board member at innRoad, a software-as-a-service hotel management software solution. He received his MBA in Global Strategic Management from Babson College in 2006, and his B.A. in Economics from the University of Massachusetts Boston.

© Edgar Online, source Glimpses